NCT06791226View on ClinicalTrials.gov

Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 16, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Orbital Neoplasms
Interventions
DIAGNOSTIC_TEST

18F-AlF-FAPI PET/CT, 18F-FDG PET/CT

Subjects with orbital neoplasms underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT for diagnosis and staging.

Trial Locations (1)

100191

RECRUITING

Dept. of Nuclear Medicine, Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER